Downregulation of inhibitor of apoptosis‑stimulating protein of p53 inhibits proliferation and promotes apoptosis of gastric cancer cells

Wang,Lu‑Lu; Xu,Zhong; Peng,Yang; Li,Lu‑Chun; Wu,Xiao‑Ling

doi:10.3892/mmr.2015.3587

Downregulation of inhibitor of apoptosis‑stimulating protein of p53 inhibits proliferation and promotes apoptosis of gastric cancer cells

Authors:
- Lu‑Lu Wang
- Zhong Xu
- Yang Peng
- Lu‑Chun Li
- Xiao‑Ling Wu
View Affiliations

Affiliations: Department of Gastroenterology, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China, Department of Gastroenterology, Guizhou Provincial People's Hospital, The Affiliated People's Hospital of Guiyang Medical University, Guiyang, Guizhou 550002, P.R. China
Published online on: April 1, 2015 https://doi.org/10.3892/mmr.2015.3587
Pages: 1653-1658
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gastric cancer (GC) remains one of the leading causes of cancer‑associated mortality. Inhibitor of apoptosis‑stimulating protein of p53 (iASPP) is a member of the inhibitory apoptosis‑stimulating protein p53 family. The overexpression of iASPP has been detected in several types of tumor in humans. However, the role of iASPP in GC remains to be elucidated. The objectives of the present study were to detect the expression of iASPP in GC and examine the potential role of iASPP in GC cell lines. Using reverse transcription‑quantitative polymerase chain reaction and western blot analyses, it was identified that the expression of iASPP in GC tissues and GC cell lines was higher compared with that in adjacent normal tissues and in a normal gastric mucosa cell line (GES‑1). To examine the role of iASPP in GC cells, the expression of iASPP was inhibited using a small interfering (si)RNA against iASPP and it was observed that iASPP expression was significantly downregulated. Using MTT assays, colony‑formation assays and flow cytometry, it was identified that the inhibition of iASPP was able to significantly inhibit the proliferation and colony forming ability and promote apoptosis in GC cells. To examine the role of iASPP in GC cells in vivo, GC cells, which were infected with iASPP‑siRNA or control‑siRNA were subcutaneously injected into nude mice. It was identified that downregulation of iASPP significantly inhibited tumor growth in vivo. Thus, iASPP may be a potential molecular target in GC therapy.

View Figures

View References

1	Takahashi T, Saikawa Y and Kitagawa Y: Gastric cancer: current status of diagnosis and treatment. Cancers (Basel). 5:48–63. 2013. View Article : Google Scholar
2	Samuels-Lev Y, O’Connor DJ, Bergamaschi D, et al: ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell. 8:781–794. 2001. View Article : Google Scholar : PubMed/NCBI
3	Laska MJ, Vogel UB, Jensen UB and Nexø BA: p53 and PPP1R13L (alias iASPP or RAI) form a feedback loop to regulate genotoxic stress responses. Biochim Biophys Acta. 1800:1231–1240. 2010. View Article : Google Scholar : PubMed/NCBI
4	Murray-Zmijewski F, Lane DP and Bourdon JC: p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ. 13:962–972. 2006. View Article : Google Scholar : PubMed/NCBI
5	Cai Y, Qiu S, Gao X, Gu SZ and Liu ZJ: iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes. Apoptosis. 17:777–783. 2012. View Article : Google Scholar : PubMed/NCBI
6	Yang JP, Hori M, Sanda T and Okamoto T: Identification of a novel inhibitor of nuclear factor-kappaB, RelA-associated inhibitor. J Biol Chem. 274:15662–15670. 1999. View Article : Google Scholar : PubMed/NCBI
7	Notari M, Hu Y, Koch S, et al: Inhibitor of apoptosis-stimulating protein of p53 (iASPP) prevents senescence and is required for epithelial stratification. Proc Natl Acad Sci USA. 108:16645–16650. 2011. View Article : Google Scholar : PubMed/NCBI
8	Bergamaschi D, Samuels Y, O’Neil NJ, et al: iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet. 33:162–167. 2003. View Article : Google Scholar : PubMed/NCBI
9	Wang C, Gao CF, Chen Y, Yin J, Wang P and Lv X: Expression pattern of the apoptosis-stimulating protein of p53 family in p53⁺ human breast cancer cell lines. Cancer Cell Int. 13:1162013. View Article : Google Scholar
10	Liu ZJ, Zhang Y, Zhang XB and Yang X: Abnormal mRNA expression of ASPP members in leukemia cell lines. Leukemia. 18:8802004. View Article : Google Scholar : PubMed/NCBI
11	Chen J, Xie F, Zhang L and Jiang WG: iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway. BMC Cancer. 10:6942010. View Article : Google Scholar
12	Lu B, Guo H, Zhao J, et al: Increased expression of iASPP, regulated by hepatitis B virus X protein-mediated NF-κB activation, in hepatocellular carcinoma. Gastroenterology. 139:2183–2194. 2010. View Article : Google Scholar
13	Meng WD, Chu RX, Wang BZ, et al: Helicobacter pylori infection and expressions of apoptosis-related proteins p53, ASPP2 and iASPP in gastric cancer and precancerous lesions. Pathol Biol (Paris). 61:199–202. 2013. View Article : Google Scholar
14	Yokozaki H: Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol Int. 50:767–777. 2000. View Article : Google Scholar : PubMed/NCBI
15	Xue Z, Yan H, Li J, et al: Identification of cancer stem cells in vincristine preconditioned SGC7901 gastric cancer cell line. J Cell Biochem. 113:302–312. 2012. View Article : Google Scholar
16	Li GL, Wang RZ, Gao J, et al: RNA interference-mediated silencing of iASPP induces cell proliferation inhibition and G0/G1 cell cycle arrest in U251 human glioblastoma cells. Mol Cell Biochem. 350:193–200. 2011. View Article : Google Scholar
17	Zhang B, Xiao HJ, Chen J, Tao X and Cai LH: Inhibitory member of the apoptosis-stimulating protein of p53 (ASPP) family promotes growth and tumorigenesis in human p53-deficient prostate cancer cells. Prostate Cancer Prostatic Dis. 14:219–224. 2011. View Article : Google Scholar : PubMed/NCBI
18	Lin BL, Xie DY, Xie SB, Xie JQ, Zhang XH, Zhang YF and Gao ZL: Down-regulation of iASPP in human hepatocellular carcinoma cells inhibits cell proliferation and tumor growth. Neoplasma. 58:205–210. 2011. View Article : Google Scholar : PubMed/NCBI
19	Liu ZJ, Cai Y, Hou L, et al: Effect of RNA interference of iASPP on the apoptosis in MCF-7 breast cancer cells. Cancer Invest. 26:878–882. 2008. View Article : Google Scholar : PubMed/NCBI
20	Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
21	Lu X: p53: a heavily dictated dictator of life and death. Curr Opin Genet Dev. 15:27–33. 2005. View Article : Google Scholar : PubMed/NCBI
22	Suzuki K and Matsubara H: Recent advances in p53 research and cancer treatment. J Biomed Biotechnol. 2011:9783122011. View Article : Google Scholar : PubMed/NCBI
23	Patel S, George R, Autore F, Fraternali F, Ladbury JE and Nikolova PV: Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax. Nucleic Acids Res. 36:5139–5151. 2008. View Article : Google Scholar : PubMed/NCBI
24	Bergamaschi D, Samuels Y, Jin B, Duraisingham S, Crook T and Lu X: ASPP1 and ASPP2: common activators of p53 family members. Mol Cell Biol. 24:1341–1350. 2004. View Article : Google Scholar : PubMed/NCBI